OpenLegislation

Title II AUTHORISATION AND SUPERVISION OF MEDICINAL PRODUCTS FOR HUMAN USEF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 1Submission and examination of applications — Authorisations
  2. 2Supervision and penalties
  3. 3Pharmacovigilance

Annotations

Textual amendments

F1

Regulation revoked insofar as it applies to medicinal products for veterinary use (31.12.2020) by The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/676), regs. 1(2)(b), 5; 2020 c. 1, Sch. 5 para. 1(1)

Regulation revoked insofar as it applies to medicinal products for human use (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), Sch. 9 para. 1(h) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)